Deal net: 6 – 10 February 2017

The Global Government Venturing deal net rounds up all the latest smaller deals and tracks emerging companies accessing government funds.

Atriva Therapeutics, a Germany-based developer of antiviral therapies, has received an undisclosed amount in seed funding co-led by public-private partnership High-Tech Gründerfonds and Stichting Participatie Artriva. A range of private investors also participated in the round, which will support the advancement of the startup’s therapy for influenza into the clinical development stage.

See more from this Government Report: Germany

Back

Copyright Mawsonia Limited 2010. Please don't cut articles from www.globalgovernmentventuring.com or the PDF and redistribute by email or post to the web without written permission.

Most read

  1. Spire enters $70m series C orbit

    November 16, 2017

  2. Big deal: PIF puts $1bn into space companies

    October 30, 2017

  3. BioGeneration Ventures III grows to $95m

    October 31, 2017

  4. News round up 30 October 2017

    October 30, 2017

  5. Yotpo generates $51m series D

    November 10, 2017